World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
88
Citations
26333
World Ranking
1173
National Ranking
621

Medicine

D-Index
88
Citations
26333
World Ranking
13242
National Ranking
6745

Robert T. Bailer publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Robert T. Bailer sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 159 publications — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Robert T. Bailer D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Robert T. Bailer sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 88 D-Index — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Robert T. Bailer is affiliated with the National Institute of Allergy and Infectious Diseases in the United States. Their research spans multiple areas in medicine, with a particular focus on infectious diseases and immunology.

Their main fields of study include Medicine and Immunology and Microbiology. Within these fields, their work concentrates on subfields such as Infectious Diseases, Virology, Epidemiology, Radiology, Nuclear Medicine and Imaging, and Public Health, Environmental and Occupational Health.

The primary topics addressed in their research are diverse, highlighting areas such as HIV Research and Treatment, HIV/AIDS drug development and treatment, Monoclonal and Polyclonal Antibodies Research, Respiratory viral infections research, Viral Infections and Outbreaks Research, Immune Cell Function and Interaction, and Glycosylation and Glycoproteins Research.

Robert T. Bailer has authored several papers, with notable recent publications including:

  • Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial, 2022, Nature Medicine
  • Effect of a Chikungunya Virus-Like Particle Vaccine on Safety and Tolerability Outcomes, 2020, JAMA
  • Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial, 2021, The Lancet Respiratory Medicine
  • Neutralizing antibody VRC01 failed to select for HIV-1 mutations upon viral rebound, 2020, Journal of Clinical Investigation
  • Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trials, 2024, npj Vaccines

The scientist frequently collaborates with a number of peers in their field. Frequent co-authors include:

  • John R. Mascola
  • Ingelise J. Gordon
  • Nina M. Berkowitz
  • Cynthia S. Hendel
  • Richard A. Koup

Their publications appear in respected venues such as UNC Libraries, Nature Medicine, JAMA, The Lancet Respiratory Medicine, and npj Vaccines.

Best Publications

  • Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial

    Barton F. Haynes;Peter B. Gilbert;M. Juliana McElrath;Susan Zolla-Pazner

  • Broad and potent neutralization of HIV-1 by a gp41-specific human antibody

    Jinghe Huang;Gilad Ofek;Leo Laub;Mark K. Louder

  • Structure and immune recognition of trimeric pre-fusion HIV-1 Env

    Marie Pancera;Tongqing Zhou;Aliaksandr Druz;Ivelin S. Georgiev

  • Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies.

    Nicole A. Doria-Rose;Chaim A. Schramm;Jason Gorman;Penny L. Moore

  • Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1.

    Marcella Sarzotti-Kelsoe;Robert T. Bailer;Ellen Turk;Chen-li Lin

  • Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8+ T cell responses

    Melissa L. Precopio;Michael R. Betts;Janie Parrino;David A. Price

  • Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption

    Katharine J Bar;Michael C Sneller;Linda J Harrison;J Shawn Justement

  • Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection

    Rebecca M. Lynch;Eli Boritz;Emily E. Coates;Adam DeZure

  • Broad and potent HIV-1 neutralization by a human antibody that binds the gp41–gp120 interface

    Jinghe Huang;Byong H. Kang;Marie Pancera;Jeong Hyun Lee

  • Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection

    Peter Hraber;Michael S. Seaman;Robert T. Bailer;John R. Mascola

  • Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth.

    Jinghe Huang;Byong H. Kang;Elise Ishida;Tongqing Zhou

  • Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env

    Young Do Kwon;Marie Pancera;Priyamvada Acharya;Ivelin S. Georgiev

  • Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV‐1 Candidate Vaccine Delivered by a Replication‐Defective Recombinant Adenovirus Vector

    Andrew T. Catanzaro;Richard A. Koup;Mario Roederer;Robert T. Bailer

  • Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody

    Rui Kong;Kai Xu;Tongqing Zhou;Priyamvada Acharya

  • Global Panel of HIV-1 Env Reference Strains for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies

    Allan deCamp;Peter Hraber;Robert T. Bailer;Michael S. Seaman

  • Chimpanzee Adenovirus Vector Ebola Vaccine

    Julie E. Ledgerwood;Adam D. DeZure;Daphne A. Stanley;Emily E. Coates

  • Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses

    M. Gordon Joyce;Adam K. Wheatley;Paul V. Thomas;Gwo-Yu Chuang

  • Structural basis for diverse N-glycan recognition by HIV-1–neutralizing V1–V2–directed antibody PG16

    Marie Pancera;Syed Shahzad-Ul-Hussan;Nicole A. Doria-Rose;Jason S. McLellan

  • Structural repertoire of HIV-1-neutralizing antibodies targeting the CD4 supersite in 14 donors

    Tongqing Zhou;Rebecca M. Lynch;Lei Chen;Priyamvada Acharya

  • Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody

    Mattia Bonsignori;Tongqing Zhou;Zizhang Sheng;Lei Chen

Frequent Co-Authors

John R. Mascola
John R. Mascola ModeX Therapeutics
Richard A. Koup
Richard A. Koup National Institute of Allergy and Infectious Diseases
Barney S. Graham
Barney S. Graham Morehouse School of Medicine
Mark K. Louder
Mark K. Louder National Institute of Allergy and Infectious Diseases
Julie E. Ledgerwood
Julie E. Ledgerwood National Institute of Allergy and Infectious Diseases
Peter D. Kwong
Peter D. Kwong Columbia University Medical Center
Ivelin S. Georgiev
Ivelin S. Georgiev Vanderbilt University Medical Center
Gary J. Nabel
Gary J. Nabel ModeX Therapeutics
Sijy O'Dell
Sijy O'Dell National Institute of Allergy and Infectious Diseases
Mario Roederer
Mario Roederer National Institute of Allergy and Infectious Diseases

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can broaden career opportunities. Many students pursue advanced nursing roles, such as Psychiatric-Mental Health Nurse Practitioners (PMHNPs), which support individuals with immune-related mental health conditions. Programs listed among the best online pmhnp programs combine flexible learning with strong clinical placements, essential for hands-on experience.

Cost is often a critical consideration. Prospective students should review the cheapest psych np programs to find affordable pathways toward psychiatric nurse practitioner certification, which complements expertise in immunologically linked psychiatric disorders.

For nurse practitioners aiming for specialization, transitioning from Family Nurse Practitioner to roles like Acute Care Nurse Practitioner often requires certification. Guidance on this process can be found in resources like acute care nurse practitioner certification, enabling practitioners to manage complex immunology-related acute cases.

Finally, understanding salary expectations is crucial when choosing a career path. Data on highest paid dnp specialties reveals that roles integrating immunology knowledge can be financially rewarding, aligning passion with professional growth.

Best Scientists Citing Robert T. Bailer

Trending Scientists

Recently Published Articles